首页> 外国专利> use of a combination of at least two selected compounds of baclofen, acamprosate, cinacalcet, mexiletine, sulfisoxazole and torasemide, or sustained release salt, prodrug (s) or formulation (s)

use of a combination of at least two selected compounds of baclofen, acamprosate, cinacalcet, mexiletine, sulfisoxazole and torasemide, or sustained release salt, prodrug (s) or formulation (s)

机译:至少两种选定的巴氯芬,阿坎酸,西那卡塞,美西律汀,磺胺异恶唑和托拉塞米的化合物或缓释盐,前药或制剂的组合使用

摘要

summary use of a combination of at least two selected compounds of baclofen, acamprosate, cinacalcet, mexiletine, sulfisoxazole and torasemide, or salt, prodrug (s), derivative (s) or sustained release formulation (s) The invention itself relates to compositions and methods for improving memory and related functions such as alertness, attention, concentration, learning and language processing. More particularly, the invention relates to compositions comprising at least two drugs selected from cinacalcet, baclofen, acamprosate, mexiletine, sulfisoxazole and torasemide useful for enhancing memory and memory-related functions in healthy subjects or individuals suffering from conditions or disorders. that have a negative impact on your memory. 1/1
机译:至少两种选定的巴氯芬,阿坎酸,西那卡塞,美西律汀,磺胺异恶唑和托拉塞米的化合物或盐,前药,衍生物或缓释制剂的组合的概括用途本发明本身涉及组合物和改善记忆力和相关功能(例如警觉性,注意力,注意力,学习和语言处理)的方法。更具体地,本发明涉及包含选自西那卡塞特,巴氯芬,阿坎酸,美西律汀,磺胺异恶唑和托拉塞米的至少两种药物的组合物,其可用于增强健康受试者或患有状况或病症的个体的记忆和与记忆相关的功能。对您的记忆力有负面影响。 1/1

著录项

  • 公开/公告号BR112015004843A2

    专利类型

  • 公开/公告日2017-07-04

    原文格式PDF

  • 申请/专利权人 PHARNEXT;

    申请/专利号BR20151104843

  • 申请日2013-09-04

  • 分类号A61K31/135;A61K31/137;A61K31/185;A61K31/195;A61K31/44;A61K31/635;A61P25;A61P25/16;A61P25/18;A61P25/24;A61P25/36;A61P39/02;A61P43;

  • 国家 BR

  • 入库时间 2022-08-21 13:40:17

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号